Edit
Petrichor Healthcare Capital Management
https://www.petrichorcap.comLast activity: 05.03.2025
Active
Petrichor Healthcare Capital Management partners with world-class healthcare managers and businesses providing customized investment structures and support. The Petrichor team has substantial experience in healthcare finance and believes that our long-duration capital combined with our flexible mandate to execute across sectors, geographies, and capital structures provides a competitive advantage. For further information, please visit: www.petrichorcap.com.
Location: United States, New York
Employees: 1-10
Persons 4
| Date | First Name | Last Name | Title | Location | |||
| - | Patrick | Lally | Partner | linkedin.c... | - | p****y@pet... | - |
| - | Tadd | Wessel | Managing P... | linkedin.c... | - | t*****l@pe... | - |
| - | Hayden | Fownes | Senior Ass... | linkedin.c... | - | h*****s@pe... | - |
| - | Michael | Beecham | Partner | linkedin.c... | - | m******m@p... | - |
Mentions in press and media 10
| Date | Title | Description |
| 05.03.2025 | Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director | ROCKVILLE, Md., March 5, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen Flynn as non-executive members of its Board of... |
| 19.12.2024 | Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management | ~ $13 Million Convertible Debt Repayment from Available Cash ~ ~ Elimination of Approximately $1.5 Million in Annual Interest Expense and Potential Equity Overhang of Approximately 1.6 Million Shares ~ RESEARCH TRIANGLE PARK, N.C., Dec. 19,... |
| 18.04.2024 | Evergreen Theragnostics Secures $26M to Drive Radiopharmaceutical Innovation | Evergreen Theragnostics, a cutting-edge radiopharmaceutical company based in Springfield, NJ, has successfully completed a $26M capital raise, with support from Petrichor and LIFTT. This funding will propel the company's groundbreaking rese... |
| 16.04.2024 | Evergreen Theragnostics Completes $26M Capital Raise to Advance Novel Radiopharmaceutical Pipeline into the Clinic, Prepare for First Commercial Product Launch, and Expand Industry-Leading CDMO Servic... | SPRINGFIELD, N.J., April 16, 2024 /PRNewswire/ -- Evergreen Theragnostics, Inc., a clinical-stage radiopharmaceutical company, today announced the successful completion of a $26M capital raise supported both by existing shareholders and new... |
| 05.01.2023 | Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million to Accelerate Late-Stage Development and Support Commercialization of Novel Therapies for Serious, Rare Genetic Skin Diseases | Led by new investor Petrichor, with participation from new and existing investors Lead product candidate, QTORIN™ rapamycin, in late-stage clinical development for serious, rare genetic skin diseases with no FDA-approved therapies Top-line ... |
| 22.08.2022 | Fennec Pharmaceuticals Closes First $5 Million Investment From Petrichor | ~ Under the Terms of the Investment Agreement, $5 Million to be Funded on initial closing and $20 Million to be Funded Upon Potential FDA Approval of PEDMARKTM ~ ~ Fennec Has the Potential to Access an Additional $20 Million Prior to Decemb... |
| 01.08.2022 | Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor | ~ Under the Terms of the Investment Agreement, $5 Million to be Funded on initial closing and $20 Million to be Funded Upon Potential FDA Approval of PEDMARKTM ~ ~ Fennec Has the Potential to Access an Additional $20 Million Prior to Decemb... |
| 23.06.2021 | Leukocare : Announces USD 17.5 million Financing Round to Further Expand US Business and Bioinformatics Activities | DGAP-News: LEUKOCARE AG / Key word(s): Financing Leukocare Announces USD 17.5 million Financing Round to Further Expand US Business and Bioinformatics Activities 23.06.2021 / 09:30 The issuer is solely responsible for the content of this an... |
| 23.06.2021 | Leukocare Announces USD 17.5 Million Financing Round to Further Expand US Business and Bioinformatics Activities | MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., June 23, 2021 (GLOBE NEWSWIRE) -- Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation development, today announced the closing of a USD... |
| 23.10.2017 | Archean Capital Partners Invests in Petrichor Healthcare Capital Management | PHILADELPHIA & NEW YORK--(BUSINESS WIRE)--Archean Capital Partners, a private market investment platform established by Veritable, L.P. and Moelis Asset Management LP announced a $100 million anchor capital commitment by Archean Capital... |